For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

singup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies you may be eligible for. 4

Based on the information you provided, we found the following studies.

  • A Phase 2 Study of investigational drug XL184 (Cabozantinib) in Recurrent or Metastatic Endometrial Cancer Study purpose: see how useful XL184 is in treating recurrent or metastatic endometrial cancer.XL184 blocks receptors called receptor tyrosine kinases (RTKs).It is believed that by blocking these receptors from receiving signals for the tumor cells to grow, the tumor may stop growing or shrink. This study is researching all of the following topics: Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • An Open-Label, Phase 2 Study of Neratinib in Patients With Solid Tumors With Somatic Human Epidermal Growth Factor Receptor Mutations or EGFR gene amplification Study purpose: find out what effects, good and/or bad, experimental drug neratinib has in patients with a cancer that has a certain type of mutation: solid tumors that test positive for HER2 and HER3 mutations or EGFR (Epidermal Growth Factor Receptor) mutation or amplification in brain tumors. This study is researching all of the following topics: Bladder cancer Breast cancer Colon Cancer ( Malignant tumor of colon ) Esophagus cancer Ovarian cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase I safety study of intratumoral injection of Clostridium novyi-NT spores in patients with treatment-refractory solid tumor malignancies This study is being done to learn whether treatment with Clostridium novyi-NT spores (NT refers to non-toxin producing) is safe and effective in patients with advanced cancers that can no longer be controlled with standard therapy or cancers for which there is no standard effective treatment. This study is researching all of the following topics: Adrenal cancer BCC, Basal cell skin cancer Bladder cancer Bone cancer Breast cancer Cervical cancer Colon Cancer ( Malignant tumor of colon ) Esophagus cancer Fallopian tube cancer HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer Lymphoma NPC, Nasal cancer Oral / Mouth cancer Ovarian cancer Pancreatic cancer Prostate cancer Salivary Gland Cancer Sarcoma Squamous cell skin cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase 1b, Open-label Study of Oral BGJ398 in Combination with Oral BYL719 in Adult Patients with Select Advanced Solid Tumors This clinical research study is to determine how much of experimental drugs BGJ398 and BYL719 can safely be given in combination to patients. Researchers would like to know how much of these two drugs can be given without causing serious side effects and also how these two drugs affect your body. This study is researching all of the following topics: Brain cancer Breast cancer Cervical cancer Colon Cancer ( Malignant tumor of colon ) HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Lung cancer Ovarian cancer Pancreatic cancer Prostate cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old